Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Retrospective Observational (Descriptive) Study of Second-line Therapies After Progression to CDK4/6i in Association With Hormone Therapy, in Patients With HR+/HER2- Advanced Breast Cancer (HERMIONE 13)

NCT05173103 is registered in ClinicalTrials.gov with University of Milano Bicocca as lead sponsor.

NCT NCT05173103
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05173103 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Retrospective Observational (Descriptive) Study of Second-line Therapies After Progression to CDK4/6i in Association With Hormone Therapy, in Patients With HR+/HER2- Advanced Breast Cancer (HERMIONE 13)
Lead sponsor
University of Milano Bicocca
Phase
Observational
Overall status
Completed
Start date
September 24, 2021
Completion date
December 30, 2024
Enrollment
254 (actual)
Sites
29

Conditions

As the registry lists them; a condition with its own page is linked.

advanced breast cancer, her2-negative breast cancer, hormone receptor positive breast carcinoma